Trials / Terminated
TerminatedNCT02962076
Study of Cardiac PET/CT Imaging to Guide Ablation Treatment of Ventricular Tachycardia
Cardiac Positron Emission Tomography for Detection of Cardiac Sympathetic Dysinnervation to Guide Ablation of Ventricular Tachycardia
- Status
- Terminated
- Phase
- EARLY_Phase 1
- Study type
- Interventional
- Enrollment
- 11 (actual)
- Sponsor
- Khaled Awad, MD · Academic / Other
- Sex
- All
- Age
- 18 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
Imaging is to be performed prior to procedure using positron emission tomography/ computed tomography (PET/CT), after a special dye is injected. The scans are going to be merged with other cardiac scans when doing the ablation procedure to correlate anatomy with physiology.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | [C-11] Meta-hydroxyephedrine radioactive tracer (MHED) | this tracer detects the distribution of sympathetic nerve fibers in the left ventricle |
Timeline
- Start date
- 2020-09-21
- Primary completion
- 2023-03-01
- Completion
- 2024-10-31
- First posted
- 2016-11-11
- Last updated
- 2024-12-24
- Results posted
- 2024-12-24
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT02962076. Inclusion in this directory is not an endorsement.